Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

USANA Colombia receives 2015 Editors' Choice Award from NutriSearch

It's been nearly two years since USANA began operations in Colombia, and USANA Colombia has been named the sole GOLD Medal recipient for Colombian products in the recently released 2015 NutriSearch Comparative Guide to Nutritional Supplements for the Americas.

30 Jun 2015

CMC Biologics expands North American manufacturing facility with addition of Bioreactor 6Pack facility

CMC Biologics, Inc., a global leader in clinical and commercial manufacturing of monoclonal antibodies and other therapeutic proteins, announced today that, as part of its global manufacturing capacity expansion strategy, it has completed the expansion of its North American manufacturing facility in Bothell, Washington with the addition of a single-use Bioreactor 6Pack™ facility.

30 Jun 2015

Egalet reports top-line results from Category 3 HAL study of Egalet-002

Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative pain treatments, today announced top-line results from a Category 3 human abuse liability (HAL) study of Egalet-002, an abuse-deterrent, extended-release, oral oxycodone product candidate in late-stage clinical development for the management of pain severe enough to require daily, around-the-clock opioid treatment and for which alternative treatments are inadequate.

30 Jun 2015

Government of the Republic of Equatorial Guinea to sponsor development of Sanaria PfSPZ Vaccine for malaria

The Government of the Republic of Equatorial Guinea announced an agreement with industry partners, Marathon Oil Corporation, Noble Energy Inc. and AMPCO, to sponsor the clinical development of Sanaria PfSPZ Vaccine against malaria, including a series of clinical trials from 2015 until 2018.

30 Jun 2015

Tris, Pfizer Consumer Healthcare sign agreement to market extended-release Robitussin for treatment of cough

Tris Pharma, Inc. today announced that it has entered into a license, supply, and distribution agreement with Pfizer Consumer Healthcare.

29 Jun 2015

IDC Marketscape recognizes TCS as Leader in Worldwide Life Sciences R&D Risk-Based Monitoring

Tata Consultancy Services, a leading global IT services, consulting and business solutions organization, announced that it has been designated as a Leader in Worldwide Life Sciences R&D Risk-Based Monitoring by global market intelligence firm, IDC, in the "IDC MarketScape: Worldwide Life Science R&D Risk-Based Monitoring 2015 Vendor Assessment," (doc #HI255628, April 2015) report.

27 Jun 2015

Kenall Manufacturing introduces light fixture to kill harmful bacteria linked to HAIs

Kenall Manufacturing today introduced Indigo-Clean, a light fixture that uses Continuous Environmental Disinfection technology to continuously kill harmful bacteria linked to hospital acquired infections (HAIs). The technology behind Indigo-Clean inactivates a wide range of micro-organisms that are known causes of HAIs, including MRSA (Methicillin-resistant Staphylococcus aureus), C.difficile and VRE (Vancomycin-resistant Enterococcus).

27 Jun 2015

SeraCare Life Sciences inks CRADA with NCI to create positive controls for cancer assays

SeraCare Life Sciences, a leading partner to global in vitro diagnostics manufacturers, today announced that it has signed a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute, part of the National Institutes of Health, to create reference materials and positive controls for cancer assays.

26 Jun 2015

ATL Technology expands global footprint with acquisition of MedConx

ATL Technology, LLC, a top provider of electromechanical contract manufacturing of assemblies and devices with specialties in single use solutions, headquartered in Springville, Utah, has announced the acquisition of MedConx, Inc. (a California corporation with locations in Santa Clara, CA, and San Jose, Costa Rica).

26 Jun 2015

Novasep to build fully integrated Antibody Drug Conjugate facility at Le Mans site in France

Novasep, a leading supplier of services and technologies for the life sciences industry, today announces it will build a fully integrated Antibody Drug Conjugate (ADC) facility at its Le Mans site in France. The new facility will enable Novasep to complement its current ADC offering with full bio-conjugation services to meet increasing market demand.

25 Jun 2015

Biontech, Siemens enter into strategic collaboration on manufacture of personalized cancer vaccines

Siemens and BioNTech AG, a fully integrated biotechnology company developing truly personalized cancer immunotherapies, have entered into a strategic collaboration.

25 Jun 2015

IDT’s fully licensed MGB Eclipse qPCR probes available for online ordering

Integrated DNA Technologies (IDT), has become the only company to add fully licensed Minor Groove Binder (MGB) Eclipse GMP probes to its online service, enabling quick and efficient ordering.

From Integrated DNA Technologies 25 Jun 2015

TxCell’s pilot manufacturing facility activities put on temporary partial hold

TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that it has temporarily put its pilot manufacturing facility activities at Besançon, France on partial hold.

24 Jun 2015

Florida State Board of Pharmacy approves Unique Pharmaceuticals' license for sterile distribution

UNIQUE PHARMACEUTICALS, a 503B current Good Manufacturing Practices (CGMP) Outsourcing Facility, today announced its licensure approval in Florida. The Florida State Board of Pharmacy review committee approved Unique Pharmaceuticals' license June 10 for distribution of sterile and non-sterile compounded medications.

23 Jun 2015

Ontario announces $25 million investment to support new treatments for people with chronic diseases

Ontario is investing $25 million over five years to support new treatments and therapies for people living with chronic diseases, such as cancer, multiple sclerosis and diabetes.

23 Jun 2015

3SBio obtains ex-China global rights to Apexigen's anti-TNF mAb technology

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it has acquired the ex-China global rights to Apexigen's anti-TNF monoclonal antibody ("mAb") technology. 3SBio previously acquired the China rights from Apexigen in 2006.

23 Jun 2015

Picosun provides advanced ALD coating solutions to enhance medical technology

Picosun Oy, the leading supplier of high quality Atomic Layer Deposition (ALD) technology for industrial manufacturing, provides the advanced ALD coating solutions to enable the next generation of cutting-edge medical technology.

23 Jun 2015

Wockhardt obtains final approval from FDA for marketing 5mg/ 5ml of Oxycodone HCl liquid

Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing 5mg/ 5ml of Oxycodone HCl liquid which is used in treatment of moderate to severe acute and chronic pain. Wockhardt is launching the product soon and will be amongst the few generic versions of this product in the market.

22 Jun 2015

ScinoPharm Taiwan, Raffles PharmaTech collaborate to manufacture Celecoxib

ScinoPharm Taiwan, Ltd. and Raffles PharmaTech announced today the collaboration to manufacture "Celecoxib," a non-steroidal and anti-inflammatory analgesic active pharmaceutical ingredient (API).

22 Jun 2015

ZEISS and University of California Berkeley launch public-private partnership to support brain microscopy Innovation Center

ZEISS announces that it is participating in a new public-private partnership with UC Berkeley as part of the Brain Microscopy Innovation Center (BrainMIC), a component of the Berkeley BRAIN Initiative.

From ZEISS Microscopy GmbH 22 Jun 2015

Manufacturing News and Research

Further Reading

USANA Colombia receives 2015 Editors' Choice Award from NutriSearch

CMC Biologics expands North American manufacturing facility with addition of Bioreactor 6Pack facility

Egalet reports top-line results from Category 3 HAL study of Egalet-002

Government of the Republic of Equatorial Guinea to sponsor development of Sanaria PfSPZ Vaccine for malaria

Tris, Pfizer Consumer Healthcare sign agreement to market extended-release Robitussin for treatment of cough

IDC Marketscape recognizes TCS as Leader in Worldwide Life Sciences R&D Risk-Based Monitoring

Kenall Manufacturing introduces light fixture to kill harmful bacteria linked to HAIs

SeraCare Life Sciences inks CRADA with NCI to create positive controls for cancer assays

ATL Technology expands global footprint with acquisition of MedConx

Novasep to build fully integrated Antibody Drug Conjugate facility at Le Mans site in France

Biontech, Siemens enter into strategic collaboration on manufacture of personalized cancer vaccines

IDT’s fully licensed MGB Eclipse qPCR probes available for online ordering

TxCell’s pilot manufacturing facility activities put on temporary partial hold

Florida State Board of Pharmacy approves Unique Pharmaceuticals' license for sterile distribution

Ontario announces $25 million investment to support new treatments for people with chronic diseases

3SBio obtains ex-China global rights to Apexigen's anti-TNF mAb technology

Picosun provides advanced ALD coating solutions to enhance medical technology

Wockhardt obtains final approval from FDA for marketing 5mg/ 5ml of Oxycodone HCl liquid

ScinoPharm Taiwan, Raffles PharmaTech collaborate to manufacture Celecoxib

ZEISS and University of California Berkeley launch public-private partnership to support brain microscopy Innovation Center

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®